NOWDx

How To Use Our Technology

Fingerstick Tests

Perform fingerstick test

Lance fingertip. Touch drop to test. Tap. Set it down. Wait 10 minutes. Visually interpret result.

Saliva Tests

Perform saliva test

Spit into test. Set it down. Wait 15 minutes. Visually interpret result.

Collection Device

Collect sample

Lance fingertip. Touch drop to test. Wait 10 minutes. Separate blood from plasma. Seal test components into pouch.

Analyzer

Digitally read result

Scan test pouch. Insert test into Analyzer. Select ‘Run Test’. View result.

Featured Tests

COVID-19 Test

hCG Test

Explore Our Tests

“Love the blood hCG tests for patients”

– Lisa Fonkalsrud

Tulsa Endoscopy Center

“Separating plasma from whole blood in a rapid test cassette is a remarkable technology”

– Alper Sever

Mutlu Medikim

“The ADEXUSDx® COVID-19 Test is easy to set up and easy to use”

– Grant Womack

Medical Arts Pharmacy

“I received excellent service from the NOWDiagnsotics' Customer Care Team”

– Mark Gronberg

AdventHealth Shawnee Mission

“The customer service team gives excellent support and has a quick response time”

– Grant Womack

Medical Arts Pharmacy

“The ADEXUSDx® COVID-19 antibody test is a great way for pharmacists to be involved in the patient’s healthcare plan”

– Julie Stewart

Pharmacist

Check out what is making the news

Find out the latest in diagnostics testing.

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

October 16, 2024

As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settingsNOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-ca...

NOWDiagnostics First To Know® Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

August 16, 2024

First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announce...

NOWDiagnostics Secures $22.5 Million in Series B Funding

July 9, 2024

SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced it has raised $22.5 million in Series B financing. Led by DigitalDx Ventures, with notable inves...